Brief: Giant Biogene Posts HY Revenue RMB2.54 Billion
19/08/2024 13:03
Aug 19 (Reuters) - Giant Biogene Holding Co Ltd
2367.HK :
* HY REVENUE RMB2.54 BILLION
Further company coverage: 2367.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan